Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (201-210 of 1,137) with videos related to

Pageof 114
Sort By:
Developmental Genetics|July 14, 1999
Gene trap screening using negative selection: identification of two tandem, differentially expressed loci with potential hematopoietic functionJ P Cannon, S M Colicos, J W Belmont
The Journal of the Oklahoma State Medical Association|July 1, 1982
Septicemia in general surgery patients incidence and characterization at a veteran's hospitalB M Miller, D J Flournoy, J P Cannon
Journal of the American College of Cardiology|November 15, 1995
Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II InvestigatorsC Hall, C P Cannon, S Forman, et al.
The New Zealand Medical Journal|October 1, 1971
Ross SmithT P Cannon, J M Louisson, P M Tripp
Clinical Cardiology|February 4, 1999
The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery diseaseM J Tanasijevic, C P Cannon, E M Antman
Journal of General Internal Medicine|March 14, 2007
Gender differences in aspirin use among adults with coronary heart disease in the United StatesAlexander R Opotowsky, J Michael McWilliams, Christopher P Cannon
American Heart Journal|October 31, 2007
New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?John P Morrow, Christopher P Cannon, James A Reiffel
JAMA Cardiology|January 3, 2020
Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-ReplyRichard G Bach, Christopher P Cannon, Michael A Blazing
American Journal of Surgery|December 1, 1985
Pancreatic pseudocysts: cause, therapy, and resultsV P O'Malley, J P Cannon, R G Postier
Molecular Biology of the Cell|April 4, 1998
Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertilityL A Rudolph-Owen, P Cannon, L M Matrisian
Pageof 114

Showing results (201-210 of 1,137) with videos related to

Sort By:
Pageof 114
Developmental Genetics|July 14, 1999
Gene trap screening using negative selection: identification of two tandem, differentially expressed loci with potential hematopoietic functionJ P Cannon, S M Colicos, J W Belmont
The Journal of the Oklahoma State Medical Association|July 1, 1982
Septicemia in general surgery patients incidence and characterization at a veteran's hospitalB M Miller, D J Flournoy, J P Cannon
Journal of the American College of Cardiology|November 15, 1995
Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II InvestigatorsC Hall, C P Cannon, S Forman, et al.
The New Zealand Medical Journal|October 1, 1971
Ross SmithT P Cannon, J M Louisson, P M Tripp
Clinical Cardiology|February 4, 1999
The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery diseaseM J Tanasijevic, C P Cannon, E M Antman
Journal of General Internal Medicine|March 14, 2007
Gender differences in aspirin use among adults with coronary heart disease in the United StatesAlexander R Opotowsky, J Michael McWilliams, Christopher P Cannon
American Heart Journal|October 31, 2007
New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?John P Morrow, Christopher P Cannon, James A Reiffel
JAMA Cardiology|January 3, 2020
Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-ReplyRichard G Bach, Christopher P Cannon, Michael A Blazing
American Journal of Surgery|December 1, 1985
Pancreatic pseudocysts: cause, therapy, and resultsV P O'Malley, J P Cannon, R G Postier
Molecular Biology of the Cell|April 4, 1998
Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertilityL A Rudolph-Owen, P Cannon, L M Matrisian
Pageof 114